BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20221026T080000 DTEND;TZID=America/New_York:20221026T093000 DTSTAMP:20240329T092035 CREATED:20221020T195942Z LAST-MODIFIED:20221020T200023Z UID:6565-1666771200-1666776600@bioct.org SUMMARY:GNHCC: Advancements & Challenges in Breast Cancer Treatment DESCRIPTION:Join us for another Councils and Conversation! For this C-Squared we will focus on Advances and Challenges in Breast Cancer Treatment and Outcomes – A Conversation with Eric Winer\, the new Director at the Yale cancer center. \nAs a monthly networking and seminar event: C-Squared Councils & Conversation offers the opportunity for business professionals from companies of all types and sizes to come together for networking and educational programming. Come network with Chamber Members & the regional business community! We are planning a light agenda to give YOU more time to network in person \n\n8:00 AM\nAttendee Registration\, Breakfast & Networking \n8:30 AM\nPresentation URL:https://bioct.org/event/gnhcc-advancements-challenges-in-breast-cancer-treatment/ END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221026T110000 DTEND;TZID=America/New_York:20221026T130000 DTSTAMP:20240329T092035 CREATED:20220826T132710Z LAST-MODIFIED:20221021T135951Z UID:6130-1666782000-1666789200@bioct.org SUMMARY:Come Be an Angel: Angel Investing 101 DESCRIPTION:Have you ever thought that you’d like to help early stage companies grow but you don’t know enough about the process? Or that you’d like to be part of an angel network but you don’t know where to start? \n  \nCome join the angel conversation that we’re starting at HAYVN in October. HAYVN is partnering with Tidal River\, a new CT-based group of women investors who will be leading the conversation about what you need to know to evaluate early stage/seed investment opportunities. \n  \nChristine\, Sullivan\, CT SBDC Consultant\, Alison Malloy\, Tidal River Co-Founder and Connecticut Innovations Director of Investments; and Galia Gichon\, Tidal River Deal Flow Manager and Down to Earth Finance Founder\, will discuss topics including pitch evaluation\, due diligence\, valuation\, financials and term sheets. You’ll learn the critical questions to ask entrepreneurs and you’ll get some practice with real women with innovative ideas that they’re currently pitching. \n  \nA three-day workshop over lunch that combines investor assessment techniques with guest pitches from real entrepreneurs. \n  \nGeneral Admission: $120 (includes lunch) \nDates: Wednesday\, October 12\, 19 & 26 \nLocation: HAYVN\, 320 Boston Post Road Suite 180 Darien\, CT 06820 \n  \nAbout the speakers: \nChristine Sullivan is a consultant at the CT Small Business Development Center. She enjoys helping entrepreneurs and small business owners achieve their next milestone. Whether it’s developing a business plan or finding the right source of capital\, Christine can help advise on the best plan to achieve the company’s short- and long-term goals. Prior to joining CTSBDC\, Christine worked in investment banking for nearly 20 years where she focused on technology and food and beverage companies. During her career\, she realized how rewarding it was to work with earlier stage businesses where you could see that your advice was having a real impact on the company’s growth and success. With a passion for organic and natural food\, Christine spent two years working for Revolution Foods\, a b-corp focused on providing healthy school lunches to schools in low income communities. Her interest in healthy food and innovative food business ideas continues and she loves experiencing the exciting Connecticut foodie scene! \nGalia Gichon serves on the Tidal River leadership team and assists with managing deal flow. She is also an independent personal financial expert whose career has spanned corporate bond research analyst\, personal finance expert\, angel investor\, entrepreneur advisor and author. As an angel investor\, she actively supports women-led and impact startups. She is the founder of Down to Earth Finance\, providing independent personal finance education. Galia teaches at Barnard College’s Athena Center for Leadership and Freelancers Union\, and is often asked for comment by the New York Times\, NBC\, CNN and other media outlets. Previously\, she worked at Bear Stearns and Nomura Securities. Galia is the author of My Money Matters\, which was featured on the Today show\, and of the novel The Accidental Suffragist. \nAlison Malloy is co-founder of Tidal River and primarily helps manage the group’s deal flow. She is also director of investments at CI\, where she is responsible for evaluating investment opportunities\, structuring investments and accelerating portfolio companies through active board participation. Alison was the CEO and co-founder of Design2Launch (D2L)\, a leading Connecticut-based tech startup in workflow collaboration for the pharmaceuticals industry that she helped sell twice. After D2L was initially acquired by Eastman Kodak Company in 2008\, Alison worked on the spinout and merger with BLUE Software in 2016\, where she served on the board of directors and supported the successful exit for the second time to Danaher in 2018. Alison previously worked at the Slovak American Enterprise Fund and Trimodia LLC. She worked for General Electric around the world\, graduating from GE Capital’s prestigious financial management program. URL:https://bioct.org/event/come-be-an-angel-angel-investing-101-3/ LOCATION:HAYVN Coworking END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221026T130000 DTEND;TZID=America/New_York:20221026T160000 DTSTAMP:20240329T092035 CREATED:20221012T171916Z LAST-MODIFIED:20221012T171916Z UID:6522-1666789200-1666800000@bioct.org SUMMARY:3rd Annual Connecticut Regional Cybersecurity & Tech Virtual Expo DESCRIPTION:The University of New Haven\, the Connecticut Institute of Technology\, and the Connecticut Career Consortium are proud to present the third annual Regional Cybersecurity & Tech Expo! \nThe facts: \n\nThere are 1 million open positions in cyber security around the world\n17 schools from the Northeast have joined forces to make your search for talent easier\nConnect with qualified students studying\, researching\, and building their paths to success in the cyber security and technology fields\n\nMeet students on a virtual platform! Open drop-in booths and pre-scheduled meetings are available. \nA virtual career fair brings higher quality interactions with students. We offer: \n\nPre-Scheduled Meetings with Students: During the pre-scheduling period leading up to the fair\, students may request specific timeframes to meet with you during the fair. Approve up to 15 minute conversations per student.\nOpen Virtual Drop In Booth: you can host a virtual open booth where students come in and out to meet with you via chat and video. This option most closely approximates a traditional career fair experience.\nPre-Schedule and Drop In Booth: to get the best of both worlds\, you can pre-schedule and host an open drop in booth. You will need more than one attending representative to manage this process.\n\nProcess: \nOnce you register\, a representative from the University of New Haven will connect with you to build your booth and your preferences for pre-scheduling\, drop in\, or both. We will also send out all the materials\, timelines\, and information you will need to manage your booth. Visit this resources page for more info. \nRegister: \nCreate (or access) your account in ChargerLink\, powered by AcadeME\, and click on the Cyber Expo link to register today. \nDiscounts are available for our non-profit and government partners\, and combo packages with our Fall Career Expo on Sept 15 are available as well! URL:https://bioct.org/event/3rd-annual-connecticut-regional-cybersecurity-tech-virtual-expo/ END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20221026T150000 DTEND;TZID=America/New_York:20221026T160000 DTSTAMP:20240329T092035 CREATED:20220922T155414Z LAST-MODIFIED:20220922T155414Z UID:6275-1666796400-1666800000@bioct.org SUMMARY:Academic Drug Discovery Support by TRxA - Hosted by UConn TCS DESCRIPTION:The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining and funding optimal strategies for advancing new\, cutting-edge therapeutics from the lab to patients. TRxA’s nonprofit accelerator model accomplishes this by: \n• Providing resources and hands-on guidance\, with TRxA staff working closely with academic researchers to develop a comprehensive data package for potential drug candidates. \n• Providing tactical and strategic drug discovery and development guidance\, bringing diverse expertise to pivotal early-stage study design and implementation. \n• Leveraging TRxA’s outsourcing model to facilitate involvement of contract research organizations (CROs) as necessary to perform critical experiments that cannot be conducted in the academic setting (e.g.\, key toxicology and other specialized studies). CROs may also be engaged for third-party validation of academic studies to develop the type of comprehensive and validated data package pharmaceutical companies require when making decisions about licensing opportunities. \nTRxA will have a call for proposals in early 2023 and eligibility criteria will be reviewed during this presentation \nSpeaker: Maaike Everts \nMaaike Everts\, PhD\, a pharmaceutical scientist with broad experience in drug delivery\, discovery and development\, is Executive Director of the Critical Path Institute’s Translational Therapeutics Accelerator. Prior to C-Path\, she had a leadership role with Parenteral Drug Delivery Solutions at Evonik Health Care\, responsible for shaping the drug delivery technology and manufacturing platforms offered by the organization as well as positioning them in the marketplace. Before joining Evonik\, Maaike was a full professor at the University of Alabama at Birmingham (UAB)\, in the School of Medicine\, where she structured and lead the Alabama Drug Discovery Alliance\, a venture between UAB and Southern Research\, and the Antiviral Drug Discovery and Development Consortium\, funded by the National Institutes of Health. She had been at UAB since 2002\, initially as a postdoctoral scholar in its Gene Therapy Center\, where she combined adenoviral based vectors with nanotechnology. She received her Ph.D. in Pharmacokinetics and Drug Delivery from the University of Groningen in the Netherlands. URL:https://bioct.org/event/academic-drug-discovery-support-by-trxa-hosted-by-uconn-tcs/ LOCATION:VIRTUAL END:VEVENT END:VCALENDAR